Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

other basic supportive treatment

PreclinicalSmall molecule

CChildren's Hospital of Fudan University

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Henoch-Schönlein PurpuraRecruiting

Henoch-Schönlein PurpuraPreclinical

Recruiting

Timeline

Expected Milestones

Q4 2026

Henoch-Schönlein Purpura

NCT03647852

Clinical

Trials by Indication[1]

Henoch-Schönlein Purpura1 trial

Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura

Recruiting·—·N/A·NCT03647852·150 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for other basic supportive treatment. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — other basic supportive treatment compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for other basic supportive treatment. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Children's Hospital of Fudan University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CChildren's Hospital of Fudan University

Related News